Basilea Launches Antifungal CRESEMBA (isavuconazole) In Germany - Quick Facts - Nasdaq

Basilea Launches Antifungal CRESEMBA (isavuconazole) In Germany - Quick Facts Nasdaq ... such as patients with cancer and after transplantation. Invasive aspergillosis is often fatal, while Mucormycosis (also known as zygomycosis) is a rapidly progressive and life-threatening invasive fungal infection, often affecting the nose and ...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Y8RLhS
via IFTTT